The largest database of trusted experimental protocols

5 protocols using abt 263

1

Multi-Compound Cytotoxicity Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following chemicals were used: 2c [9 (link)], dimethyl sulfoxide (DMSO), Doxorubicin, MK2206, Torin1, Bafilomycin A1, Chloroquine, ABT263 (Sigma), Gemcitabine, XMD8-92, YKL-06-061, ABT199 (CSN Scientific), Selumetinib, TMP195, MKC3946 (MedChemExpress), SAHA (Cayman Chemicals), NKL54 [46 (link)].
+ Open protocol
+ Expand
2

Evaluation of Compound Treatments on Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were treated either with ABT-263 (Selleck Chemicals, Houston, TX, USA), quercetin (Sigma-Aldrich, St. Louis, MO, USA), nicotinamide riboside (ChromaDex, Irvine, CA, USA), or danazol (Sigma-Aldrich). These compounds were dissolved in DMSO (VWR, Radnor, PA, USA) (ABT-263), ethanol (VWR) (quercetin and danazol), or phosphate-buffered saline (Sigma-Aldrich) (nicotinamide riboside), according to the manufacturer’s instructions, and subsequently diluted in cell culture medium to working concentrations of 10 μM (ABT-263), 100 μM (quercetin and danazol), or 20 mM (nicotinamide riboside). If not stated otherwise, the compounds were applied only for 3 days.
+ Open protocol
+ Expand
3

Gefitinib-Resistant Cell Culture and Reagents

Check if the same lab product or an alternative is used in the 5 most similar protocols
PC-9 gefitinib-resistant cells (PC-9-GR) was kindly provided by Dr. Bing Xia at Hangzhou Cancer Hospital (Hangzhou, China) [16 (link)]. H1975 cell lines was obtained from the American Type Culture Collection (Manassas, VA, USA). Cells were cultured in standard RPMI-1640 media (Invitrogen, Carlsbad, CA, USA) supplemented with 10 % heat-inactivated fetal bovine serum (Invitrogen, Carlsbad, CA, USA), 2 mM l-glutamine, and 1 % penicillin/streptomycin at 37 °C in a humidified incubator with 5 % CO2. AT-101, ABT-263, and gefitinib were purchased from Sigma (St. Louis, MO, USA). Both reagents were dissolved in dimethyl sulfoxide (DMSO), stored at−80 °C, and diluted in culture medium for described experiments.
+ Open protocol
+ Expand
4

Mitochondrial Dynamics in Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lines were selected to give a broad overview of multiple cancer types, including breast, ovarian, pancreatic, and hematologic cancers. All cell lines except A2780, A2780-cis and patient derived lines were obtained from ATCC and cultured as directed. Patient-derived cell lines were obtained and cultured as previously described28 (link). Briefly, patient-derived cells were obtained from ovarian cancer patients and were cultured under identical conditions as described28 (link). The A2780 and cisplatin-resistant A2780 cell lines were obtained from Sigma-Aldrich. These cell lines were transduced with a mitochondrial targeted-GFP using a lentiviral construct consisting of mito-PAGFP (Addgene Plasmid #23348), where the mitochondrial targeting sequence and GFP were cut and inserted into a pLVX-AcGFP1-C1 Vector backbone (Clonetech #632155). Lentivirus production was completed following a standard protocol29 (link). cisplatin and ABT-263 were obtained from Sigma-Aldrich and dissolved in DMF and DMSO, respectively, prior to cell treatment.
+ Open protocol
+ Expand
5

Renal Cell Carcinoma Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human RCC cells (786-O and Caki-1) were obtained from Shanghai Bank for Cell Culture (Shanghai, China). All cells were cultured in RPMI-1640 medium (Life Technologies, USA) supplemented with 10% FBS (Gibco, USA). Cells were maintained in humidified atmosphere with 5% CO2 at 37°C. TW-37, ABT-263 and all other chemicals were obtained from Sigma-Aldrich (St Louis, USA). TW-37 and ABT-263 were dissolved in DMSO at a stock solution of 100 mM and diluted with FBS-free medium to achieve desired concentrations.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!